U.S. Insulin Pump Market Size & Outlook, 2024-2030
U.S. insulin pump market, 2018-2030 (US$M)
Related Markets
U.S. insulin pump market highlights
- The U.S. insulin pump market generated a revenue of USD 2,407.3 million in 2024 and is expected to reach USD 3,943.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.4% from 2025 to 2030.
- In terms of segment, tethered pumps was the largest revenue generating type in 2024.
- Patch Pumps is the most lucrative type segment registering the fastest growth during the forecast period.
Insulin pump market data book summary
| Market revenue in 2024 | USD 2,407.3 million |
| Market revenue in 2030 | USD 3,943.8 million |
| Growth rate | 8.4% (CAGR from 2025 to 2030) |
| Largest segment | Tethered pumps |
| Fastest growing segment | Patch Pumps |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Patch Pumps, Tethered Pumps |
| Key market players worldwide | Medtronic PLC, Roche Holding AG ADR, Tandem Diabetes Care Inc, Insulet Corp, Ypsomed Holding AG, Zealand Pharma A/S, CellNovo, SOOIL Developments |
Other key industry trends
- In terms of revenue, U.S. accounted for 40.8% of the global insulin pump market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. insulin pump market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,943.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Pump Market Scope
Insulin Pump Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. insulin pump market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin pump market will help companies and investors design strategic landscapes.
Tethered pumps was the largest segment with a revenue share of 84.41% in 2024. Horizon Databook has segmented the U.S. insulin pump market based on patch pumps, tethered pumps covering the revenue growth of each sub-segment from 2018 to 2030.
The insulin pumps market in U.S. held the largest market share in 2024 in the North America region. The growth can be attributed to the presence of major market players in this country such as Medtronic, Hoffmann-La Roche AG, Tandem Diabetes Care, Inc., Insulet Corporation and others.
Furthermore, the increasing prevalence of obesity, high treatment costs, technological advancement, and product launches are also expected to drive the market in the region. In March 2024, Abbott highlighted its partnership with Tander diabetic care.
The combination of Abbott's FreeStyle Libre sensor and Tandem Diabetes Care's insulin pumps enabled real-time glucose monitoring and automatic insulin delivery adjustments. This advancement aimed to enhance patient outcomes by providing more accurate and responsive diabetes management.
Reasons to subscribe to U.S. insulin pump market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. insulin pump market databook
-
Our clientele includes a mix of insulin pump market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. insulin pump market , including forecasts for subscribers. This country databook contains high-level insights into U.S. insulin pump market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. insulin pump market size, by type, 2018-2030 (US$M)
U.S. Insulin Pump Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
